CA
SGMO

Commerzbank Aktiengesellschaft’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-201,577
Closed -$1.14M – 1182
2015
Q3 		$1.14M Buy
+201,577
New +$1.66M 0.01% 551

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Commerzbank Aktiengesellschaft's SGMO Position: Q4 2015 in Review

Commerzbank Aktiengesellschaft sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2015, closing a stake of 201,577 shares — an estimated $1.14M sold.

Commerzbank Aktiengesellschaft first reported a position in SGMO in Q3 2015 and held it in 1 quarter. The position peaked at $1.14M in Q3 2015. 141 funds tracked by Wall St. Rank hold SGMO as of Q4 2015.

  • Commerzbank Aktiengesellschaft reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2015 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 201,577 SANGAMO THERAPEUTICS INC shares in Q4 2015, an estimated $1.14M.
  • Commerzbank Aktiengesellschaft first reported a position in SANGAMO THERAPEUTICS INC in Q3 2015 and held it in 1 quarter.
  • Commerzbank Aktiengesellschaft's SANGAMO THERAPEUTICS INC position peaked at $1.14M in Q3 2015.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2015, filed 5 Feb 2016.